LifeStance Health Group Inc (LFST) concluded trading on Wednesday at a closing price of $6.81, with 3.24 million shares of worth about $22.06 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -0.58% during that period and on Wednesday the price saw a gain of about 1.04%. Currently the company’s common shares owned by public are about 382.74M shares, out of which, 109.64M shares are available for trading.
Stock saw a price change of -0.58% in past 5 days and over the past one month there was a price change of -14.88%. Year-to-date (YTD), LFST shares are showing a performance of -7.60% which increased to 7.08% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.64 but also hit the highest price of $8.61 during that period. The average intraday trading volume for LifeStance Health Group Inc shares is 1.44 million. The stock is currently trading -8.32% below its 20-day simple moving average (SMA20), while that difference is down -11.97% for SMA50 and it goes to 0.69% higher than SMA200.
LifeStance Health Group Inc (NASDAQ: LFST) currently have 382.74M outstanding shares and institutions hold larger chunk of about 35.06% of that.
The stock has a current market capitalization of $2.62B and its 3Y-monthly beta is at 1.30. It has posted earnings per share of -$0.15 in the same period. It has Quick Ratio of 1.37 while making debt-to-equity ratio of 0.34. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for LFST, volatility over the week remained 3.31% while standing at 4.27% over the month.
Stock’s fiscal year EPS is expected to rise by 41.33% while it is estimated to increase by 101.57% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on December 16, 2024 offering a Buy rating for the stock and assigned a target price of $10 to it. Coverage by Barclays stated LifeStance Health Group Inc (LFST) stock as an Underweight in their note to investors on January 03, 2024, suggesting a price target of $7 for the stock. On May 15, 2023, TD Cowen Downgrade their recommendations, while on January 06, 2023, Morgan Stanley Upgrade their ratings for the stock with a price target of $8. Stock get a Buy rating from Jefferies on November 07, 2022.
